Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Andreas Fontalis, Eustathios Kenanidis, Rafail Angelos Kotronias, Afroditi Papachristou, Panagiotis Anagnostis, Michael Potoupnis & Eleftherios Tsiridis. (2019) Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss. Expert Opinion on Pharmacotherapy 20:9, pages 1123-1134.
Read now
Read now
Miriam Carr, Andrew J. S. Knox, David G. Lloyd, Daniela M. Zisterer & Mary J. Meegan. (2016) Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells. Journal of Enzyme Inhibition and Medicinal Chemistry 31:sup3, pages 117-130.
Read now
Read now
Pailla Umareddy & Veera Reddy Arava. (2016) Total synthesis of lasofoxifene and nafoxidine. Synthetic Communications 46:4, pages 309-313.
Read now
Read now
Luigi Gennari, Daniela Merlotti, Konstantinos Stolakis & Ranuccio Nuti. (2012) Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis. Expert Opinion on Drug Metabolism & Toxicology 8:4, pages 505-513.
Read now
Read now
Luigi Gennari, Daniela Merlotti & Ranuccio Nuti. (2010) Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene. Clinical Interventions in Aging 5, pages 19-29.
Read now
Read now
Luigi Gennari, Daniela Merlotti & Ranuccio Nuti. (2009) Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis. Expert Review of Obstetrics & Gynecology 4:6, pages 607-617.
Read now
Read now
Luigi Gennari. (2009) Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy. Expert Opinion on Pharmacotherapy 10:13, pages 2209-2220.
Read now
Read now
Chang Bai, Osvaldo Flores & Azriel Schmidt. (2007) Opportunities for development of novel therapies targeting steroid hormone receptors. Expert Opinion on Drug Discovery 2:5, pages 725-737.
Read now
Read now
Articles from other publishers (32)
Jake J. Blackner, Deirdre M. Rooney, Joshua W. Hollett & J. Adam McCubbin. (2023) Ferrocenium Boronic Acid Catalyzed Deoxygenative Coupling of Alcohols with Carbon- and Nitrogen-Based Borate and Silane Nucleophiles. The Journal of Organic Chemistry 88:13, pages 8505-8511.
Crossref
Crossref
Satavisha Sarkar, Arghya Banerjee & Ming‐Yu Ngai. (2022) Synthesis of Ketonylated Carbocycles via Excited‐State Copper‐Catalyzed Radical Carbo‐Aroylation of Unactivated Alkenes. ChemCatChem 15:1.
Crossref
Crossref
Nalini Schaduangrat, Aijaz Ahmad Malik & Chanin Nantasenamat. (2021) ERpred: a web server for the prediction of subtype-specific estrogen receptor antagonists. PeerJ 9, pages e11716.
Crossref
Crossref
Nitin Tandon, Vijay Luxami, Runjhun Tandon & Kamaldeep Paul. (2020) Recent Advances in the Synthesis of Tamoxifen and Analogues in Medicinal Chemistry. Asian Journal of Organic Chemistry 9:10, pages 1432-1465.
Crossref
Crossref
Bernhard Kutscher. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry
1
22
.
Jie Jack Li. 2020. Medicinal Chemistry for Practitioners. Medicinal Chemistry for Practitioners
1
96
.
Jasna Markovac & Robert Marcus. 2020. Principles of Bone Biology. Principles of Bone Biology
863
893
.
Aman U. Buzdar, Shaheenah Dawood, Harold A. Harvey & Virgil Craig Jordan. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
26
.
Hwee Ting Ang, Jason P. G. Rygus & Dennis G. Hall. (2019) Two-component boronic acid catalysis for increased reactivity in challenging Friedel–Crafts alkylations with deactivated benzylic alcohols. Organic & Biomolecular Chemistry 17:24, pages 6007-6014.
Crossref
Crossref
Anna Czarnecka, Emilia Kowalska, Agnieszka Bodzioch, Joanna Skalik, Marek Koprowski, Krzysztof Owsianik & Piotr Bałczewski. (2018)
A selective removal of the secondary hydroxy group from
ortho
-dithioacetal-substituted diarylmethanols
. Beilstein Journal of Organic Chemistry 14, pages 1229-1237.
Crossref
Crossref
Carin C.C. Johansson Seechurn, Ivana Gazić Smilović, Thomas Colacot, Antonio Zanotti-Gerosa & Zdenko Časar. (2018) Development of concise two-step catalytic approach towards lasofoxifene precursor nafoxidine. Bioorganic & Medicinal Chemistry 26:9, pages 2691-2697.
Crossref
Crossref
Aman U. Buzdar, Shaheenah Dawood, Harold A. Harvey & Virgil Craig Jordan. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
24
.
Antonio Zanotti-Gerosa, Ivana Gazić Smilović & Zdenko Časar. (2017) Acid promoted Ir–P^N complex catalyzed hydrogenation of heavily hindered 3,4-diphenyl-1,2-dihydronaphthalenes: asymmetric synthesis of lasofoxifene tartrate. Organic Chemistry Frontiers 4:12, pages 2311-2322.
Crossref
Crossref
Primali V. Navaratne & Alexander J. Grenning. (2017) Deconjugative alkylation/Heck reaction as a simple platform for dihydronaphthalene synthesis. Organic & Biomolecular Chemistry 15:1, pages 69-75.
Crossref
Crossref
Niamh M. O’Boyle, Jade K. Pollock, Miriam Carr, Andrew J. S. Knox, Seema M. Nathwani, Shu Wang, Laura Caboni, Daniela M. Zisterer & Mary J. Meegan. (2014) β-Lactam Estrogen Receptor Antagonists and a Dual-Targeting Estrogen Receptor/Tubulin Ligand. Journal of Medicinal Chemistry 57:22, pages 9370-9382.
Crossref
Crossref
Barry S. Komm & Sebastian Mirkin. (2014) An overview of current and emerging SERMs. The Journal of Steroid Biochemistry and Molecular Biology 143, pages 207-222.
Crossref
Crossref
Sankalan Mondal & Gautam Panda. (2014) Synthetic methodologies of achiral diarylmethanols, diaryl and triarylmethanes (TRAMs) and medicinal properties of diaryl and triarylmethanes-an overview. RSC Adv. 4:54, pages 28317-28358.
Crossref
Crossref
Pritesh Kumar & Zhao-Hui Song. (2014) CB2 cannabinoid receptor is a novel target for third-generation selective estrogen receptor modulators bazedoxifene and lasofoxifene. Biochemical and Biophysical Research Communications 443:1, pages 144-149.
Crossref
Crossref
Shu-Yan Yu, Zhi-Long Hu, Hao Zhang, Shaozhong Wang & Zhu-Jun Yao. (2012) Electronically unfavorable addition of electron-deficient olefins to isochromenylium tetrafluoroborates initiated by C-1 O-glycosylation. Tetrahedron Letters 53:22, pages 2765-2768.
Crossref
Crossref
Gregory T. Wurz & Michael W. DeGregorio. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
26
.
Gregory M Peterson, Mark Naunton, Lisette K Tichelaar & Luigi Gennari. (2011) Lasofoxifene: Selective Estrogen Receptor Modulator for the Prevention and Treatment of Postmenopausal Osteoporosis. Annals of Pharmacotherapy 45:4, pages 499-509.
Crossref
Crossref
Marta Piñeiro‐Núñez. 2010. Modern Drug Synthesis. Modern Drug Synthesis
307
327
.
. (2010) Lasofoxifene for Postmenopausal Women with Osteoporosis. New England Journal of Medicine 362:23, pages 2227-2229.
Crossref
Crossref
A. Rogers, S.J. Glover & R. Eastell. (2009) A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy. Bone 45:6, pages 1044-1052.
Crossref
Crossref
C. Punyadeera, R. Kamps, S. Defrère, F. Dijcks, A. de Goeij, A. Ederveen, G. Dunselman & P. Groothuis. (2008) Effects of selective oestrogen receptor modulators on proliferation in tissue cultures of pre- and postmenopausal human endometrium. The Journal of Steroid Biochemistry and Molecular Biology 112:1-3, pages 102-109.
Crossref
Crossref
Chandra Prakash, Kim A. Johnson, Clinton M. Schroeder & Michael J. Potchoiba. (2008) Metabolism, Distribution, and Excretion of a Next Generation Selective Estrogen Receptor Modulator, Lasofoxifene, in Rats and Monkeys. Drug Metabolism and Disposition 36:9, pages 1753-1769.
Crossref
Crossref
Gerrit H. Veeneman. 2008. Nuclear Receptors as Drug Targets. Nuclear Receptors as Drug Targets
65
126
.
Chandra Prakash, Kim A. Johnson & Mark J. Gardner. (2008) Disposition of Lasofoxifene, a Next-Generation Selective Estrogen Receptor Modulator, in Healthy Male Subjects. Drug Metabolism and Disposition 36:7, pages 1218-1226.
Crossref
Crossref
Wendy Shelly, Michael W. Draper, Venkatesh Krishnan, Mayme Wong & Robert B. Jaffe. (2008) Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings. Obstetrical & Gynecological Survey 63:3, pages 163-181.
Crossref
Crossref
Byung Hwa JungMyung Jae JeonSang Wook Bai. (2008) Hormone-Dependent Aging Problems in Women. Yonsei Medical Journal 49:3, pages 345.
Crossref
Crossref
Henry U. Bryant. 2008. Principles of Bone Biology. Principles of Bone Biology
887
919
.
J. Sean Space, Alex M. Opio, Beverly Nickerson, Hong Jiang, Monica Dumont & Mark Berry. (2007) Validation of a dissolution method with HPLC analysis for lasofoxifene tartrate low dose tablets. Journal of Pharmaceutical and Biomedical Analysis 44:5, pages 1064-1071.
Crossref
Crossref